Article ID Journal Published Year Pages File Type
5833931 International Immunopharmacology 2012 6 Pages PDF
Abstract
► BW006 was tested as adjuvant for MHSP65-HER2. ► BW006 enhanced the prophylactic and therapeutic effect of MHSP65-HER2. ► BW006 enhanced the humarol but not cellular response of MHSP65-HER2. ► MHSP65-HER2 at lower dose induced more effective anti-tumor effect.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , , ,